30 Day Trial

aap Gains Funding to Support Antibacterial Silver Coating Technology
November 19, 2019, 12:00 pm
aap Implantate received a funding commitment of up to €0.7 million (~USD $0.8 million) to conceive and qualify a human clinical study to support market approval of its antibacterial silver coating technology.

Life Spine's CENTERLINE Modular Spinal System in Limited Launch
November 19, 2019, 12:00 pm
Life Spine commenced limited launch of the CENTERLINE® Modular Thoracolumbar Spinal System, and announced initial surgeries. Full launch is slated for early 2020.

Cerapedics Gains FDA Approval of PMA Supplement for i-FACTOR
November 18, 2019, 11:45 am
FDA approved Cerapedics' Premarket Approval supplement for i-FACTOR® Peptide Enhanced Bone Graft for use in ACDF to treat degenerative cervical disc disease.

Active Implants' NUsurface Artificial Meniscus Available in Israel
November 18, 2019, 11:45 am
Two patients in Israel have undergone knee surgery with Active Implants' NUsurface® Meniscus Implant, the first artificial meniscus to be marketed in the Middle East.

Paragon 28 Launches Sterile Kits for TenoTac Fixation, HammerTube Hammertoe System
November 18, 2019, 11:45 am
Paragon 28 launched sterile kit configurations for the TenoTac® Soft Tissue Fixation System for hammertoe and plantar plate repair and the HammerTube™ Hammertoe System.

OrthoPediatrics Launches PediFoot Deformity Correction in the U.S.
November 18, 2019, 11:45 am
OrthoPediatrics commenced commercial U.S. launch of the PediFoot Deformity Correction System.

Medicrea Growth Driven by U.S. Sales of Patient-Specific Implants
November 14, 2019, 2:00 pm
Medicrea reports 3Q19 revenue of €8.2MM (USD $9.2MM), +12.3% vs. 3Q18.

aap Sales Decline on U.S. Distribution Loss
November 14, 2019, 2:00 pm
aap Implantate reports 3Q19 revenue of €2.8MM (USD $3.1MM), -0.1% vs. 3Q18.

NextStep Arthropedix Adds Blade Femoral Stem to iNSitu Hip
November 14, 2019, 2:00 pm
NextStep Arthropedix launched The Blade™, a femoral stem component for the iNSitu™ Total Hip system.

Personalized Stem Cells Clinical Trial Update
November 14, 2019, 2:00 pm
Personalized Stem Cells treated the first patients in an FDA-approved clinical trial for stem cell treatment of knee osteoarthritis.
Page Navigation
Prev
Next
Prev 2 3 4 5 6 Next

 


It's important to know that ORTHOFLASH (like many ORTHOWORLD resources) is included with Membership. The full menu of Membership benefits is outlined on this page. Still have questions? Or, would you prefer personal attention?
Fran Bursic welcomes your inquiry by phone at 440.543.2101 or via email.​

Read more from ORTHOWORLD:

 
About ORTHOWORLD | Contact Us | Our Mission | Customer Credo | Privacy Policy | Terms of Service